Immune Checkpoint Inhibitor Therapy- Induced Endocrinopathy
Condition(s):EndocrinopathyLast Updated:September 6, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):EndocrinopathyLast Updated:September 6, 2019Recruiting
Condition(s):Endocrine DiseaseLast Updated:September 17, 2019Recruiting
Condition(s):Endocrine DiseaseLast Updated:March 27, 2024Recruiting
Condition(s):Turner SyndromeLast Updated:October 30, 2023Completed
Condition(s):Pituitary ACTH Hypersecretion; Acromegaly; Diabetes Mellitus, Type 1; Primary HyperparathyroidismLast Updated:August 11, 2022Completed
Condition(s):Endocrine DisorderLast Updated:October 12, 2023Suspended
Condition(s):Gynecomastia; Endocrine System DiseasesLast Updated:November 1, 2021Unknown status
Condition(s):Cushing Syndrome; Pheochromocytoma; Conns Syndrome; Metabolic MyopathyLast Updated:October 16, 2023Terminated
Condition(s):Pregnancy-related ComplicationsLast Updated:April 20, 2018Unknown status
Condition(s):Endocrine DiseasesLast Updated:October 6, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.